Ad
related to: cannabis use disorder uncomplicated
Search results
Results From The WOW.Com Content Network
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders and ICD-10 as the continued use of cannabis despite clinically significant impairment. [2] [3]
A 2021 study found cannabis use disorder rose from 17.7% before marijuana was legalized in Canada to 24.3% after legalization. “As cannabis becomes increasingly legal and available, it’s ...
The lifetime cannabis-use rates for patients with schizophrenia, major depressive disorder or bipolar disorder are 80%, 17% and 24%, respectively, the review found.
While cannabis is generally considered a calming drug, a recent study found heavy use could have the opposite effect — potentially worsening anxiety and associated disorders.
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
Individuals who have traumatic experiences have been found to have increased overall cannabis use and higher instances of cannabis use disorder (CUD), suggestive of problematic cannabis use. [6] For example, veterans who identify as medicinal users have been shown to have a higher association with combat exposure, trauma related symptoms, and ...
Daily marijuana use among young adults has risen to record highs, with more than 1 in 10 of young adults ages 19-30 now reporting daily use, and almost half reporting use within the last year ...
Cannabis use disorder is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders as a condition requiring treatment. [107] Several drugs have been investigated in an attempt to ameliorate the symptoms of stopping cannabis use. Such drugs include bupropion, divalproex, nefazodone, lofexidine, and dronabinol.
Ad
related to: cannabis use disorder uncomplicated